We found that the CD4 and CD8 mRNA expression levels of T cells in mice treated with IL-12 gene therapy increased relative to the control, and the CD8 mRNA level expression was higher than the CD4 (Figure 4) which correlates with previous reports that IL-12 mediated tumor regression and is dependent on CD8+ T cells [22]. Here, CD8A is linked to neoplasm.